Table 3.

Clinical and immune responses

The number of spots (target - control) in 5 × 10⁴ cells assessed by an ELISPOT assay was graded as follows: –: < 5, ±: 5–10, 1+: 11–50, and 2+: >50

^§Patients who had no measurable lesion at baseline

DEX dexamethasone, N/A not assessed